Therefore, in a group of 17 newly diagnosed patients with MDS without any prior treatment, we focused on detecting possible changes in ADGRL1 gene expression in relation to ABCB1 gene expression. This evidence concerns the gene ADGRL1 and myelodysplastic syndrome.